GYNORD plus s.r.o.
- Address
- lock Available on a paid plan
Bacterial Infections and Mycoses
GYNORD plus s.r.o. conducts research on genital bacterial disorders, aiming to improve treatment options for women.
- Evaluation of new antimicrobial agents for bacterial vaginosis
- Comparative effectiveness of vaginal tablets versus creams
- Monitoring resistance trends in female genital infections
The studies seek to show that the investigational product is at least as effective as standard therapy, enhancing care for patients with this condition.
Female Urogenital Diseases and Pregnancy Complications
The site is also active in trials addressing urinary continence problems, particularly in women with excess weight.
- Testing oral agents for stress urinary incontinence
- Analyzing the influence of obesity on continence outcomes
- Measuring improvements in daily activity and quality of life
These investigations aim to demonstrate superior symptom reduction compared with placebo, offering new options for affected women.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 2 by active trials.
- 1Adamed Pharma S.A.1active
lock +1 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 634 other sites in Czechia
Therapeutic Area Benchmark — Czechia
Select a therapeutic area to compare against other sites in Czechia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Czechia
Market Share
Country: Czechia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in GYNORD plus s.r.o.
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase III, randomized, open label, non-inferiority study comparing the efficacy and safety of furazidin vaginal tablets and clindamycin vaginal cream in the local treatment of bacterial vaginosis | Adamed Pharma S.A. | Phase III | Recruiting | Feb 2026 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Clindamycin Phosphate | 1 | Unknown | 2026-02-23 | 2026-02-23 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.